These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1423291

  • 1. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
    Jaffrézou JP, Levade T, Chatelain P, Laurent G.
    Cancer Res; 1992 Dec 01; 52(23):6440-6. PubMed ID: 1423291
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP, Levade T, Thurneyssen O, Chiron M, Bordier C, Attal M, Chatelain P, Laurent G.
    Cancer Res; 1992 Mar 01; 52(5):1352-9. PubMed ID: 1737397
    [Abstract] [Full Text] [Related]

  • 3. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
    Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB.
    J Immunol; 1996 Jul 01; 157(1):297-304. PubMed ID: 8683130
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN, Pierson NR.
    Cancer Res; 1990 Feb 15; 50(4):1165-9. PubMed ID: 2297765
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.
    Jaffrézou JP, Herbert JM, Levade T, Gau MN, Chatelain P, Laurent G.
    J Biol Chem; 1991 Oct 15; 266(29):19858-64. PubMed ID: 1918089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Oct 15; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 12. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun 15; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 13. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Weintraub H.
    Cancer Treat Rep; 1984 Apr 15; 68(4):637-41. PubMed ID: 6713419
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
    Ganapathi R, Grabowski D, Rouse W, Riegler F.
    Cancer Res; 1984 Nov 15; 44(11):5056-61. PubMed ID: 6488165
    [Abstract] [Full Text] [Related]

  • 15. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
    De Jong G, Gelmon K, Bally M, Goldie J, Mayer L.
    Anticancer Res; 1995 Nov 15; 15(3):911-6. PubMed ID: 7645981
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.
    Jaffrézou JP, Chen KG, Durán GE, Muller C, Bordier C, Laurent G, Sikic BI, Levade T.
    Biochim Biophys Acta; 1995 Apr 06; 1266(1):1-8. PubMed ID: 7718613
    [Abstract] [Full Text] [Related]

  • 17. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun 06; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 18. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB, Bankusli I, Frank C, Rustum YM.
    Anticancer Res; 1990 Jun 06; 10(2A):327-32. PubMed ID: 2346306
    [Abstract] [Full Text] [Related]

  • 19. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
    Wakusawa S, Nakamura S, Tajima K, Miyamoto K, Hagiwara M, Hidaka H.
    Mol Pharmacol; 1992 Jun 06; 41(6):1034-8. PubMed ID: 1614407
    [Abstract] [Full Text] [Related]

  • 20. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.